Liver Cancer Tissue Array of 96 Samples |
| Home >> Welcome to Pantomics Price List Download |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Dedicated facility |
Catalog# LVC962 - Human liver cancer tissue array
| Lot# | Cores | Size | Cut | Format | QA/QC | Price 1Slide |
Price Pack5 |
| LVC96201 | 96 | 1.5mm | 4um | 8X12 | H&E, IHC anti-Vimentin/Cytokeratin | $120 | $480 |
|
Order:
sales@pantomics.com
or call
1-415-863-2380,
Form:
Word
or
PDF;
PDF data |
|||||||
|
Recommended applications:
For Research use only. RNA or protein liver cancer/non-tumor tissue profiling using IHC or ISH;
Antibody characterization. Description: Liver cancer tissue array, non-overlapping with LVC961, including 48 cases of uninvolved and cancerous tissues of the liver in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention. |
 |
|
Array |
Age |
Sex |
Anatomic |
Histology |
Grade |
Stage (TNM) |
Image |
|
A1,B1 |
68 |
M |
Liver |
Normal |
|
|
|
|
A2,B2 |
51 |
M |
Liver |
Normal |
|
|
|
|
A3,B3 |
42 |
M |
Liver |
Normal |
|
|
|
|
A4,B4 |
51 |
M |
Liver |
Cellular swelling |
|
|
|
|
A5,B5 |
49 |
F |
Liver |
Cellular swelling |
|
|
|
|
A6,B6 |
60 |
M |
Liver |
Cellular swelling |
|
|
|
|
A7,B7 |
47 |
M |
Liver |
Fatty change |
|
|
|
|
A8,B8 |
54 |
M |
Liver |
Viral hepatitis related cirrhosis |
|
|
|
|
A9,B9 |
45 |
F |
Liver |
Viral hepatitis related cirrhosis |
|
|
|
|
A10,B10 |
50 |
M |
Liver |
Viral hepatitis related cirrhosis |
|
|
|
|
A11,B11 |
75 |
M |
Liver |
Viral hepatitis related cirrhosis |
|
|
|
|
A12,B12 |
32 |
M |
Liver |
Hemangioma |
|
|
|
|
C1,D1 |
42 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
C2,D2 |
40 |
F |
Liver |
Clear cell carcinoma |
II |
T3N0M0 |
|
|
C3,D3 |
39 |
F |
Liver |
Clear cell carcinoma |
II |
T1N0M0 |
|
|
C4,D4 |
54 |
M |
Liver |
Hepatocellular carcinoma |
I |
T1N0M0 |
|
|
C5,D5 |
57 |
M |
Liver |
Hepatocellular carcinoma |
I |
T1N0M0 |
|
|
C6,D6 |
42 |
M |
Liver |
Hepatocellular carcinoma |
I |
T1N0M0 |
|
|
C7,D7 |
60 |
M |
Liver |
Clear cell carcinoma |
II |
T1N0M0 |
|
|
C8,D8 |
50 |
M |
Liver |
Hepatocellular carcinoma |
I |
T1N0M0 |
|
|
C9,D9 |
50 |
M |
Liver |
Clear cell carcinoma |
II |
T2N0M0 |
|
|
C10,D10 |
56 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
C11,D11 |
48 |
F |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
C12,D12 |
37 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E1,F1 |
47 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E2,F2 |
32 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E3,F3 |
44 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E4,F4 |
45 |
F |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E5,F5 |
40 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E6,F6 |
32 |
F |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E7,F7 |
24 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E8,F8 |
50 |
M |
Liver |
Hepatocellular carcinoma |
II |
T4N1M0 |
|
|
E9,F9 |
44 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E10,F10 |
23 |
M |
Liver |
Hepatocellular carcinoma |
I |
T2N0M0 |
|
|
E11,F11 |
54 |
F |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
E12,F12 |
35 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
G1,H1 |
43 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
G2,H2 |
44 |
M |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
|
G3,H3 |
43 |
M |
Liver |
Hepatocellular carcinoma |
II~III |
T2N0M0 |
|
|
G4,H4 |
50 |
F |
Liver |
Hepatocellular carcinoma |
II~III |
T3N1M0 |
|
|
G5,H5 |
55 |
M |
Liver |
Hepatocellular carcinoma |
III |
T2N0M0 |
|
|
G6,H6 |
60 |
F |
Liver |
Bile duct carcinoma |
|
T2N0M0 |
|
|
G7,H7 |
63 |
F |
Liver |
Bile duct carcinoma |
|
T1N0M0 |
|
|
G8,H8 |
57 |
F |
Liver |
Cholangiocarcinoma |
|
T2N0M0 |
|
|
G9,H9 |
47 |
M |
Liver |
Mixed hepatocellular and bile duct carcinoma |
|
T2N0M0 |
|
|
G10,H10 |
66 |
M |
Liver |
Mixed hepatocellular and bile duct carcinoma |
|
T2N0M0 |
|
|
G11,H11 |
54 |
M |
Liver |
Clear cell carcinoma |
I |
T2N0M0 |
|
|
G12,H12 |
52 |
F |
Liver |
Metastatic squamous cell carcinoma |
II |
T2N0M0 |
|
-------------------------------------------------------------------------------------------------
All Products
|
Ordering Information
|
Privacy Policy
Copyright © 2004-2005,
Pantomics, Inc.
457 Mariposa Street, San Francisco, CA
94107, USA.
Tel: 415-863-2380